Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cigna Group Director's Dealing 2020

Feb 29, 2020

29918_dirs_2020-02-28_7497b84b-de9a-41cc-8b11-48faee44a88b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2020-02-26

Reporting Person: Miller Steven B (EVP, Chief Clinical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-26 Common Stock, $.01 Par Value A 1433.0000 $0.0000 Acquired 26359.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-26 Employee Stock Option (Right to Buy) $192.0200 A 5243.0000 Acquired 2030-02-26 Common Stock, $.01 Par Value (5243.0000) Direct

Footnotes

F1: These restricted shares vests in three equal annual installments beginning February 26, 2021.

F2: This option vests in three equal annual installments beginning February 26, 2021.